Almost a third of women with low-grade serous ovarian cancer, which does not respond well to chemotherapy, saw their tumours shrink or stop growing with the drugs Almost a third of women with low-grade serous ovarian cancer, which does not respond well to chemotherapy, saw their tumours shrink or stop growing with the drugs